Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Intraduodenal Acetic Acid Infusion on Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography: a Double-blind, Randomized Controlled Trial

NCT02800772 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT02800772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02800772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Intraduodenal Acetic Acid Infusion on Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography: a Double-blind, Randomized Controlled Trial
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2016
Completion date
October 31, 2017
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic duct cannulation during endoscopic retrograde choledochopancreatography